Related Experiment Video
Updated: Sep 24, 2025

Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic
Elisabet Van Loon1, Baptiste Lamarthée2, Henriette de Loor3
1Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium; Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
Abstract:
Kidney transplant injury processes are associated with molecular changes in kidney tissue, primarily related to immune cell activation and infiltration. How these processes are reflected in the circulating immune cells, whose activation is targeted by strong immunosuppressants, is poorly understood. To study this, we analyzed the molecular alterations in 384 peripheral blood samples from four European transplant centers, taken at the time of a kidney allograft biopsy, selected for their phenotype, using RNA-sequencing. In peripheral blood, differentially expressed genes in 136 rejection and 248 no rejection samples demonstrated upregulation of glucocorticoid receptor and nucleotide oligomerization domain-like receptor signaling pathways. Pathways enriched in antibody-mediated rejection (ABMR) were strongly immune-specific, whereas pathways enriched in T cell-mediated rejection were less immune related. In polyomavirus infection, upregulation of mitochondrial dysfunction and interferon signaling pathways was seen. Next, we integrated the blood results with transcriptomics of 224 kidney allograft biopsies which showed consistently upregulated genes per phenotype in both blood and biopsy. In single-cell RNASeq (scRNASeq) analysis of seven kidney allograft biopsies, the consistently overexpressed genes in ABMR were mostly expressed by infiltrating leukocytes in the allograft. Similarly, in peripheral blood scRNASeq analysis, these genes were overexpressed in ABMR in immune cell subtypes. Furthermore, overexpression of these genes in ABMR was confirmed in independent cohorts in blood and biopsy. Thus, our results highlight the immune activation pathways in peripheral blood leukocytes at the time of kidney allograft pathology, despite the use of current strong immunosuppressants, and provide a framework for future therapeutic interventions.
Insights
Kidney transplant rejection involves immune cell changes detectable in blood. This study reveals specific immune activation pathways in peripheral blood leukocytes during kidney allograft pathology, offering targets for new therapies.
Area of Science:
- Transplantation immunology
- Molecular diagnostics
- Genomics
Background:
- Kidney transplant injury is linked to molecular changes in kidney tissue, primarily immune cell activation and infiltration.
- The reflection of these processes in circulating immune cells, targeted by immunosuppressants, remains poorly understood.
Purpose of the Study:
- To investigate molecular alterations in peripheral blood immune cells during kidney transplant rejection.
- To correlate blood molecular changes with kidney allograft biopsy findings.
- To identify immune activation pathways in peripheral blood leukocytes despite immunosuppression.
Main Methods:
- RNA-sequencing of 384 peripheral blood samples from kidney transplant patients.
- Transcriptomic analysis of 224 kidney allograft biopsies.
- Single-cell RNA sequencing (scRNASeq) of seven kidney allograft biopsies and peripheral blood immune cells.
- Validation in independent cohorts.
Main Results:
- Differentially expressed genes in rejection vs. no rejection blood samples showed upregulated glucocorticoid receptor and nucleotide oligomerization domain-like receptor signaling pathways.
- Antibody-mediated rejection (ABMR) pathways were strongly immune-specific; T cell-mediated rejection pathways were less immune-related.
- Polyomavirus infection showed upregulated mitochondrial dysfunction and interferon signaling pathways.
- Blood findings were consistently mirrored in kidney allograft biopsy transcriptomics.
- scRNASeq confirmed that consistently overexpressed genes in ABMR were expressed by infiltrating leukocytes in both blood and biopsy.
Conclusions:
- Immune activation pathways are present in peripheral blood leukocytes at the time of kidney allograft pathology, even with strong immunosuppressants.
- Findings provide a molecular framework for understanding kidney transplant rejection and developing future therapeutic interventions.

